MOUNTAIN VIEW, Calif. (AP) _ ChemoCentryx Inc. (CCXI) on Tuesday reported a loss of $7.7 million in its fourth quarter.
The Mountain View, California-based company said it had a loss of 16 cents per share.
The biopharmaceutical company posted revenue of $4.9 million in the period.
For the year, the company reported that its loss widened to $40 million, or 86 cents per share. Revenue was reported as $11.9 million.
ChemoCentryx shares have dropped almost 10 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $6.69, a climb of 92 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CCXI at https://www.zacks.com/ap/CCXI
Keywords: ChemoCentryx, Earnings Report